-
公开(公告)号:EP3362075A1
公开(公告)日:2018-08-22
申请号:EP16856249.4
申请日:2016-10-14
申请人: CELULARITY, INC.
发明人: ZHANG, Xiaokui , DJURETIC, Ivana , KANG, Lin , VOSKINARIAN-BERSE, Vanessa , STOUT, Bhavani , HARIRI, Robert J. , HOFGARTNER, Wolfgang , EDINGER, James , LAW, Eric , JANKOVIC, Vladimir
IPC分类号: A61K35/17 , A61P35/00 , C12N5/0783
CPC分类号: C12N5/0646 , A61K35/17 , C12N5/0634 , C12N2501/125 , C12N2501/22 , C12N2501/2302 , C12N2501/2306 , C12N2501/2307 , C12N2501/2315 , C12N2501/30 , C12N2501/999 , C12N2506/03
摘要: Provided herein are methods of producing natural killer (NK) cells and/or ILC3 cells using a three-stage expansion and differentiation method with media comprising stem cell mobilizing factors. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein to an individual having the cancer or viral infection.
-
公开(公告)号:EP3986381A1
公开(公告)日:2022-04-27
申请号:EP20742527.3
申请日:2020-06-19
申请人: Celularity Inc.
-